Cardiology
Service
Hospital San Pedro de Alcántara
Cáceres, EspañaPublications in collaboration with researchers from Hospital San Pedro de Alcántara (17)
2024
2023
-
Spontaneous Variation of Ventriculo-Atrial Interval after Tachycardia Induction: Determinants and Usefulness in the Diagnosis of Supraventricular Tachycardias with Long Ventriculoatrial Interval
Journal of Clinical Medicine, Vol. 12, Núm. 2
-
Very long-term efficacy and safety of paclitaxel-eluting balloon after a bare-metal stent for the treatment of ST-elevation myocardial infarction: 8-year results of a randomized clinical trial (PEBSI study)
Cardiovascular Diagnosis and Therapy, Vol. 13, Núm. 5
2022
-
Complete revascularization optimizes patient outcomes in multivessel coronary artery disease: Data from the e-Ultimaster registry
Catheterization and Cardiovascular Interventions, Vol. 99, Núm. 4, pp. 961-967
-
Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life
ESC Heart Failure, Vol. 9, Núm. 5, pp. 3071-3078
-
Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry
ESC Heart Failure, Vol. 9, Núm. 4, pp. 2189-2198
-
Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 5, pp. e389-e396
2020
-
Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with st-segment elevation myocardial infarction: Vascular healing outcomes from the magstemi trial
EuroIntervention, Vol. 16, Núm. 11, pp. E913-E921
-
Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy
Heart, Vol. 106, Núm. 17, pp. 1342-1348
-
Timing of Ablation and Prognosis of Patients With Electrical Storm and Scar-Related Left Ventricular Dysfunction
American Journal of Cardiology, Vol. 136, pp. 87-93
2019
-
Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project
Clinical and experimental rheumatology, Vol. 37, Núm. 5, pp. 731-739
-
MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design
Catheterization and Cardiovascular Interventions, Vol. 93, Núm. 1, pp. 64-70
-
Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients with ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial
Circulation, Vol. 140, Núm. 23, pp. 1904-1916
2018
-
Beta-blocker therapy is associated with a lower incidence of syncope due to fast ventricular tachycardias among implantable cardioverter-defibrillator patients with left ventricular dysfunction: results from a multicenter study
Journal of Interventional Cardiac Electrophysiology, Vol. 52, Núm. 1, pp. 69-76
-
Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations
Journal of the American College of Cardiology, Vol. 72, Núm. 20, pp. 2471-2481
-
Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology, Vol. 72, Núm. 20, pp. 2457-2467